NIH Postdoctoral Fellow

Postdoctoral Associate in the laboratories of Professor E.J. Corey

The VCU College of Engineering, an innovation front-runner in academics and research, brings real-world education to Central Virginia. Our collaborative and multidisciplinary partnerships prepare undergraduate, master’s and doctoral students for leadership. Part of a premier research university, the VCU College of Engineering enhances regional and global prosperity through cutting-edge developments in tissue engineering, drug delivery, bioinformatics, cybersecurity, mechanical systems and particle science. We make it real by turning great ideas into breakthrough technologies. Our facilities are hubs of discovery, powered by an expanding student body and faculty committed to excellence.

VCU College of Engineering

Dr. Thomas Roper is a professor of Chemical Engineering and Director of the Pharmaceutical Engineering program for the School of Engineering.  He is the principal investigator for the Pharmaceuticals on Demand project at VCU, and collaborator on the Medicines for All initiative.  His research interests are in the miniaturization of manufacturing footprints, including continuous chemistry and formulation technologies.  Bringing science, technology, medicine and education close to the point of use is a major theme for his research efforts.  Roper was previously with GSK Pharmaceuticals for 22 years where his past positions included “Head of API Chemistry and Analysis US” and “Global Head of Exploratory Development Sciences”.

Metabolic Engineering and Biocatalysis

3D Printing of Dose Forms

Long Acting Therapy Development

Nanomaterials and Particle Sciences

Continuous Chemical Reaction Engineering

Cost Effective Therapeutic Treatments for the Developing World

Drug Development

Drug Discovery

Pharmaceutical Innovation

Pharmaceutical Engineering Laboratory Website

LinkedIn

Bridge between Scientists and Engineering sets stage for Medical Technologies

Fantasitc video of one of our projects: Pharmacy on Demand!

Who shrank the drug factory? Briefcase-sized labs could transform medicine

Two college faculty leaders standing in front of glass window with bottles displayed. of

VCU will open nation’s first pharmaceutical engineering doctorate program

Codirectors of new Virginia Commonwealth University Center for Pharmaceutical Engineering and Sciences.

University in Virginia starts first US pharma engineering PhD

VCU launches Center for Pharmaceutical Engineering and Sciences

Dayanjan Wijesinghe (left) and Thomas Roper

Innovative CIT Awards Projects Moving Forward

VCU steps up in state push for research collaboration with eye for commerce

Skip to main content                                         home newssenate house campaign administration business regulation media briefing room state watch latino polls 12:30 report floor action in...

The value of a cure: ensuring access and encouraging innovation

On February 28, 2017 policymakers, health officials, industry representatives and patient advocates were meeting in Washington to discuss the ‘value of a cure’ – the costs, the public health benefits and how America will move forward following the passage of the 21st Century Cures legislation.

The Act, which was signed in December promises to accelerate funding for biomedical research while it also loosens regulations governing drugs and medical equipment and devices.

Innovations in medical research and technology have produced cures and breakthrough therapies to overcome diseases that were once considered a death sentence. Polio is preventable with a vaccine, HIV is managed with a daily drug regimen, and Hepatitis C now has a cure.

But are these breakthroughs reaching all communities? How can we balance the high costs of drug development with affordability? And what can we do to ensure that new cures continue to be developed?

This is where Virginia Commonwealth University can help. Our experts are thought leaders and are some of the go-to opinions in this field.

Dr. Thomas Roper is a professor and the director of the Department of Chemical and Life Science Engineering at the VCU School of Engineering. Thomas specializes in efforts to bring engineering and science closer to patients who utilize medicines via novel technologies.

Dr. Frank Gupton is a professor and the chair of the Department of Chemical and Life Science Engineering at the VCU School of Engineering. He leads the school’s Medicines for All project that is striving to reduces costs of treatment for AIDS. He is an award-winning researcher and an expert in his field.

Both Dr. Roper and Dr. Gupton are available to speak with media regarding this very important issue. Simply click on either of their icons to arrange an interview.


The Value of a Cure and Do All Americans Benefit from Medical Breakthroughs?

the-value-of-a-cure-and-do-all-americans-benefit-from-medical-breakthroughs

Graduate Program Director, Chemical & Life Science Engineering | Director, Pharmaceutical Engineering | Engineering Foundation Professor

Floyd D. Gottwald, Jr. Chair in Pharmaceutical Engineering, Department of Chemical and Life Science Engineering

Cross-Coupling Catalysis

Flow Chemistry / Continual Chemical Processing

Organic Synthesis in Pharmaceutical Applications

On February 28, 2017 policymakers, health officials, industry representatives and patient advocates were meeting in Washington to discuss the ‘value of a cure’ – the costs, the public health benefits and how America will move forward following the passage of the 21st Century Cures legislation.

The Act, which was signed in December promises to accelerate funding for biomedical research while it also loosens regulations governing drugs and medical equipment and devices.

Innovations in medical research and technology have produced cures and breakthrough therapies to overcome diseases that were once considered a death sentence. Polio is preventable with a vaccine, HIV is managed with a daily drug regimen, and Hepatitis C now has a cure.

But are these breakthroughs reaching all communities? How can we balance the high costs of drug development with affordability? And what can we do to ensure that new cures continue to be developed?

This is where Virginia Commonwealth University can help. Our experts are thought leaders and are some of the go-to opinions in this field.

Dr. Thomas Roper is a professor and the director of the Department of Chemical and Life Science Engineering at the VCU School of Engineering. Thomas specializes in efforts to bring engineering and science closer to patients who utilize medicines via novel technologies.

Dr. Frank Gupton is a professor and the chair of the Department of Chemical and Life Science Engineering at the VCU School of Engineering. He leads the school’s Medicines for All project that is striving to reduces costs of treatment for AIDS. He is an award-winning researcher and an expert in his field.

Both Dr. Roper and Dr. Gupton are available to speak with media regarding this very important issue. Simply click on either of their icons to arrange an interview.

Source:  

Select Inquiry Type